Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Feasibility Study on the Use of Redormin® 500 (Ze 91019) on Day-time Cognition and Quality of Life in People With Occasional Sleep Problems

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05684523
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-06-12T00:05:56.036862+00:00
Published At
2026-06-11T00:00:00+00:00
Record Updated At
2026-06-11
Results Posted At
2026-06-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Sleep Disorders, Circadian Rhythm", "Cognitive Dysfunction"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-06-11"
protocolSection.identificationModule.nctId
"NCT05684523"
protocolSection.identificationModule.officialTitle
"Feasibility Study on the Use of Redormin\u00ae 500 (Ze 91019) on Day-time Cognition and Quality of Life in People With Occasional Sleep Problems"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-06-11"

Study condition terms

  • Sleep Disorders, Circadian Rhythm (protocolSection.conditionsModule.conditions)
  • Cognitive Dysfunction (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.